カテゴリ： QYResearch, 世界, 医療/バイオ

不整脈治療の世界市場2023年：ナトリウムチャネル遮断薬、ベータ遮断薬、カリウムチャネル遮断薬、カルシウムチャネル遮断薬、その他

■ 英語タイトル：Global Cardiac Arrhythmia Therapeutics Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8712）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8712
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：82
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[不整脈治療の世界市場2023年：ナトリウムチャネル遮断薬、ベータ遮断薬、カリウムチャネル遮断薬、カルシウムチャネル遮断薬、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は不整脈治療のグローバル市場について調査・分析し、世界の不整脈治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ナトリウムチャネル遮断薬、ベータ遮断薬、カリウムチャネル遮断薬、カルシウムチャネル遮断薬、その他）、用途別セグメント分析（病院、診療所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Mylan N.V.、Teva Pharmaceutical Industries Ltd、Pfizer Inc、Sanofi、Upsher-Smith Laboratories, LLC、Covis Pharma、Novartis AG、Mayne Pharma Group Limited、Eli Lilly and Companyなどが含まれています。不整脈治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、不整脈治療市場規模を算出する際に考慮しました。

・不整脈治療市場の概要
- 不整脈治療の種類別セグメント
- 世界の不整脈治療市場規模：タイプ別分析（ナトリウムチャネル遮断薬、ベータ遮断薬、カリウムチャネル遮断薬、カルシウムチャネル遮断薬、その他）
- 不整脈治療の用途別セグメント
- 世界の不整脈治療市場規模：用途別分析（病院、診療所、その他）
- 世界の不整脈治療市場規模予測（2018年-2029年）

・不整脈治療市場の成長トレンド
- 不整脈治療の地域別市場規模（2018年-2029年）
- 不整脈治療市場ダイナミクス
- 不整脈治療の業界動向
- 不整脈治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：ナトリウムチャネル遮断薬、ベータ遮断薬、カリウムチャネル遮断薬、カルシウムチャネル遮断薬、その他
- 世界の不整脈治療のタイプ別市場規模（2018年-2023年）
- 世界の不整脈治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、診療所、その他
- 世界の不整脈治療の用途別市場規模（2018年-2023年）
- 世界の不整脈治療の用途別市場規模（2024年-2029年）

・不整脈治療の地域別市場規模
- 北米の不整脈治療市場規模（2018年-2029年）
- 米国の不整脈治療市場規模（2018年-2029年）
- ヨーロッパの不整脈治療市場規模（2018年-2029年）
- アジア太平洋の不整脈治療市場規模（2018年-2029年）
- 中国の不整脈治療市場規模（2018年-2029年）
- 日本の不整脈治療市場規模（2018年-2029年）
- 韓国の不整脈治療市場規模（2018年-2029年）
- インドの不整脈治療市場規模（2018年-2029年）
- オーストラリアの不整脈治療市場規模（2018年-2029年）
- 中南米の不整脈治療市場規模（2018年-2029年）
- 中東・アフリカの不整脈治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Mylan N.V.、Teva Pharmaceutical Industries Ltd、Pfizer Inc、Sanofi、Upsher-Smith Laboratories, LLC、Covis Pharma、Novartis AG、Mayne Pharma Group Limited、Eli Lilly and Company

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Cardiac Arrhythmia Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Cardiac Arrhythmia Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cardiac Arrhythmia Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Cardiac Arrhythmia Therapeutics in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Cardiac Arrhythmia Therapeutics include Mylan N.V., Teva Pharmaceutical Industries Ltd, Pfizer Inc, Sanofi, Upsher-Smith Laboratories, LLC, Covis Pharma, Novartis AG, Mayne Pharma Group Limited and Eli Lilly and Company, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardiac Arrhythmia Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Arrhythmia Therapeutics.
The Cardiac Arrhythmia Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cardiac Arrhythmia Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiac Arrhythmia Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Mylan N.V.
Teva Pharmaceutical Industries Ltd
Pfizer Inc
Sanofi
Upsher-Smith Laboratories, LLC
Covis Pharma
Novartis AG
Mayne Pharma Group Limited
Eli Lilly and Company
Segment by Type
Sodium-channel Blockers
Beta-blockers
Potassium-channel Blockers
Calcium-channel Blockers
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiac Arrhythmia Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Arrhythmia Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sodium-channel Blockers
1.2.3 Beta-blockers
1.2.4 Potassium-channel Blockers
1.2.5 Calcium-channel Blockers
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cardiac Arrhythmia Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiac Arrhythmia Therapeutics Market Perspective (2018-2029)
2.2 Cardiac Arrhythmia Therapeutics Growth Trends by Region
2.2.1 Global Cardiac Arrhythmia Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cardiac Arrhythmia Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Cardiac Arrhythmia Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Cardiac Arrhythmia Therapeutics Market Dynamics
2.3.1 Cardiac Arrhythmia Therapeutics Industry Trends
2.3.2 Cardiac Arrhythmia Therapeutics Market Drivers
2.3.3 Cardiac Arrhythmia Therapeutics Market Challenges
2.3.4 Cardiac Arrhythmia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiac Arrhythmia Therapeutics Players by Revenue
3.1.1 Global Top Cardiac Arrhythmia Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Cardiac Arrhythmia Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Cardiac Arrhythmia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cardiac Arrhythmia Therapeutics Revenue
3.4 Global Cardiac Arrhythmia Therapeutics Market Concentration Ratio
3.4.1 Global Cardiac Arrhythmia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Arrhythmia Therapeutics Revenue in 2022
3.5 Cardiac Arrhythmia Therapeutics Key Players Head office and Area Served
3.6 Key Players Cardiac Arrhythmia Therapeutics Product Solution and Service
3.7 Date of Enter into Cardiac Arrhythmia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiac Arrhythmia Therapeutics Breakdown Data by Type
4.1 Global Cardiac Arrhythmia Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Cardiac Arrhythmia Therapeutics Forecasted Market Size by Type (2024-2029)
5 Cardiac Arrhythmia Therapeutics Breakdown Data by Application
5.1 Global Cardiac Arrhythmia Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Cardiac Arrhythmia Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cardiac Arrhythmia Therapeutics Market Size (2018-2029)
6.2 North America Cardiac Arrhythmia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cardiac Arrhythmia Therapeutics Market Size by Country (2018-2023)
6.4 North America Cardiac Arrhythmia Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiac Arrhythmia Therapeutics Market Size (2018-2029)
7.2 Europe Cardiac Arrhythmia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cardiac Arrhythmia Therapeutics Market Size by Country (2018-2023)
7.4 Europe Cardiac Arrhythmia Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiac Arrhythmia Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Cardiac Arrhythmia Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cardiac Arrhythmia Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Cardiac Arrhythmia Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiac Arrhythmia Therapeutics Market Size (2018-2029)
9.2 Latin America Cardiac Arrhythmia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cardiac Arrhythmia Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Cardiac Arrhythmia Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiac Arrhythmia Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Cardiac Arrhythmia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cardiac Arrhythmia Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Cardiac Arrhythmia Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mylan N.V.
11.1.1 Mylan N.V. Company Detail
11.1.2 Mylan N.V. Business Overview
11.1.3 Mylan N.V. Cardiac Arrhythmia Therapeutics Introduction
11.1.4 Mylan N.V. Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023)
11.1.5 Mylan N.V. Recent Development
11.2 Teva Pharmaceutical Industries Ltd
11.2.1 Teva Pharmaceutical Industries Ltd Company Detail
11.2.2 Teva Pharmaceutical Industries Ltd Business Overview
11.2.3 Teva Pharmaceutical Industries Ltd Cardiac Arrhythmia Therapeutics Introduction
11.2.4 Teva Pharmaceutical Industries Ltd Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023)
11.2.5 Teva Pharmaceutical Industries Ltd Recent Development
11.3 Pfizer Inc
11.3.1 Pfizer Inc Company Detail
11.3.2 Pfizer Inc Business Overview
11.3.3 Pfizer Inc Cardiac Arrhythmia Therapeutics Introduction
11.3.4 Pfizer Inc Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023)
11.3.5 Pfizer Inc Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Cardiac Arrhythmia Therapeutics Introduction
11.4.4 Sanofi Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 Upsher-Smith Laboratories, LLC
11.5.1 Upsher-Smith Laboratories, LLC Company Detail
11.5.2 Upsher-Smith Laboratories, LLC Business Overview
11.5.3 Upsher-Smith Laboratories, LLC Cardiac Arrhythmia Therapeutics Introduction
11.5.4 Upsher-Smith Laboratories, LLC Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023)
11.5.5 Upsher-Smith Laboratories, LLC Recent Development
11.6 Covis Pharma
11.6.1 Covis Pharma Company Detail
11.6.2 Covis Pharma Business Overview
11.6.3 Covis Pharma Cardiac Arrhythmia Therapeutics Introduction
11.6.4 Covis Pharma Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023)
11.6.5 Covis Pharma Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Detail
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Cardiac Arrhythmia Therapeutics Introduction
11.7.4 Novartis AG Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023)
11.7.5 Novartis AG Recent Development
11.8 Mayne Pharma Group Limited
11.8.1 Mayne Pharma Group Limited Company Detail
11.8.2 Mayne Pharma Group Limited Business Overview
11.8.3 Mayne Pharma Group Limited Cardiac Arrhythmia Therapeutics Introduction
11.8.4 Mayne Pharma Group Limited Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023)
11.8.5 Mayne Pharma Group Limited Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Detail
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Cardiac Arrhythmia Therapeutics Introduction
11.9.4 Eli Lilly and Company Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023)
11.9.5 Eli Lilly and Company Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cardiac Arrhythmia Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Sodium-channel Blockers
Table 3. Key Players of Beta-blockers
Table 4. Key Players of Potassium-channel Blockers
Table 5. Key Players of Calcium-channel Blockers
Table 6. Key Players of Others
Table 7. Global Cardiac Arrhythmia Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Cardiac Arrhythmia Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Cardiac Arrhythmia Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Cardiac Arrhythmia Therapeutics Market Share by Region (2018-2023)
Table 11. Global Cardiac Arrhythmia Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Cardiac Arrhythmia Therapeutics Market Share by Region (2024-2029)
Table 13. Cardiac Arrhythmia Therapeutics Market Trends
Table 14. Cardiac Arrhythmia Therapeutics Market Drivers
Table 15. Cardiac Arrhythmia Therapeutics Market Challenges
Table 16. Cardiac Arrhythmia Therapeutics Market Restraints
Table 17. Global Cardiac Arrhythmia Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Cardiac Arrhythmia Therapeutics Market Share by Players (2018-2023)
Table 19. Global Top Cardiac Arrhythmia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Arrhythmia Therapeutics as of 2022)
Table 20. Ranking of Global Top Cardiac Arrhythmia Therapeutics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Cardiac Arrhythmia Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cardiac Arrhythmia Therapeutics Product Solution and Service
Table 24. Date of Enter into Cardiac Arrhythmia Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cardiac Arrhythmia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Cardiac Arrhythmia Therapeutics Revenue Market Share by Type (2018-2023)
Table 28. Global Cardiac Arrhythmia Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Cardiac Arrhythmia Therapeutics Revenue Market Share by Type (2024-2029)
Table 30. Global Cardiac Arrhythmia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Cardiac Arrhythmia Therapeutics Revenue Market Share by Application (2018-2023)
Table 32. Global Cardiac Arrhythmia Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Cardiac Arrhythmia Therapeutics Revenue Market Share by Application (2024-2029)
Table 34. North America Cardiac Arrhythmia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Cardiac Arrhythmia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Cardiac Arrhythmia Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Cardiac Arrhythmia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Cardiac Arrhythmia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Cardiac Arrhythmia Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Cardiac Arrhythmia Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Cardiac Arrhythmia Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Cardiac Arrhythmia Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Cardiac Arrhythmia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Cardiac Arrhythmia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Cardiac Arrhythmia Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Cardiac Arrhythmia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Cardiac Arrhythmia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Cardiac Arrhythmia Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 49. Mylan N.V. Company Detail
Table 50. Mylan N.V. Business Overview
Table 51. Mylan N.V. Cardiac Arrhythmia Therapeutics Product
Table 52. Mylan N.V. Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023) & (US$ Million)
Table 53. Mylan N.V. Recent Development
Table 54. Teva Pharmaceutical Industries Ltd Company Detail
Table 55. Teva Pharmaceutical Industries Ltd Business Overview
Table 56. Teva Pharmaceutical Industries Ltd Cardiac Arrhythmia Therapeutics Product
Table 57. Teva Pharmaceutical Industries Ltd Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023) & (US$ Million)
Table 58. Teva Pharmaceutical Industries Ltd Recent Development
Table 59. Pfizer Inc Company Detail
Table 60. Pfizer Inc Business Overview
Table 61. Pfizer Inc Cardiac Arrhythmia Therapeutics Product
Table 62. Pfizer Inc Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023) & (US$ Million)
Table 63. Pfizer Inc Recent Development
Table 64. Sanofi Company Detail
Table 65. Sanofi Business Overview
Table 66. Sanofi Cardiac Arrhythmia Therapeutics Product
Table 67. Sanofi Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Upsher-Smith Laboratories, LLC Company Detail
Table 70. Upsher-Smith Laboratories, LLC Business Overview
Table 71. Upsher-Smith Laboratories, LLC Cardiac Arrhythmia Therapeutics Product
Table 72. Upsher-Smith Laboratories, LLC Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023) & (US$ Million)
Table 73. Upsher-Smith Laboratories, LLC Recent Development
Table 74. Covis Pharma Company Detail
Table 75. Covis Pharma Business Overview
Table 76. Covis Pharma Cardiac Arrhythmia Therapeutics Product
Table 77. Covis Pharma Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023) & (US$ Million)
Table 78. Covis Pharma Recent Development
Table 79. Novartis AG Company Detail
Table 80. Novartis AG Business Overview
Table 81. Novartis AG Cardiac Arrhythmia Therapeutics Product
Table 82. Novartis AG Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023) & (US$ Million)
Table 83. Novartis AG Recent Development
Table 84. Mayne Pharma Group Limited Company Detail
Table 85. Mayne Pharma Group Limited Business Overview
Table 86. Mayne Pharma Group Limited Cardiac Arrhythmia Therapeutics Product
Table 87. Mayne Pharma Group Limited Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023) & (US$ Million)
Table 88. Mayne Pharma Group Limited Recent Development
Table 89. Eli Lilly and Company Company Detail
Table 90. Eli Lilly and Company Business Overview
Table 91. Eli Lilly and Company Cardiac Arrhythmia Therapeutics Product
Table 92. Eli Lilly and Company Revenue in Cardiac Arrhythmia Therapeutics Business (2018-2023) & (US$ Million)
Table 93. Eli Lilly and Company Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiac Arrhythmia Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cardiac Arrhythmia Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Sodium-channel Blockers Features
Figure 4. Beta-blockers Features
Figure 5. Potassium-channel Blockers Features
Figure 6. Calcium-channel Blockers Features
Figure 7. Others Features
Figure 8. Global Cardiac Arrhythmia Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Cardiac Arrhythmia Therapeutics Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Cardiac Arrhythmia Therapeutics Report Years Considered
Figure 14. Global Cardiac Arrhythmia Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Cardiac Arrhythmia Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Cardiac Arrhythmia Therapeutics Market Share by Region: 2022 VS 2029
Figure 17. Global Cardiac Arrhythmia Therapeutics Market Share by Players in 2022
Figure 18. Global Top Cardiac Arrhythmia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Arrhythmia Therapeutics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Cardiac Arrhythmia Therapeutics Revenue in 2022
Figure 20. North America Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Cardiac Arrhythmia Therapeutics Market Share by Country (2018-2029)
Figure 22. United States Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Cardiac Arrhythmia Therapeutics Market Share by Country (2018-2029)
Figure 26. Germany Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Cardiac Arrhythmia Therapeutics Market Share by Region (2018-2029)
Figure 34. China Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Cardiac Arrhythmia Therapeutics Market Share by Country (2018-2029)
Figure 42. Mexico Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Cardiac Arrhythmia Therapeutics Market Share by Country (2018-2029)
Figure 46. Turkey Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Cardiac Arrhythmia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Mylan N.V. Revenue Growth Rate in Cardiac Arrhythmia Therapeutics Business (2018-2023)
Figure 49. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Cardiac Arrhythmia Therapeutics Business (2018-2023)
Figure 50. Pfizer Inc Revenue Growth Rate in Cardiac Arrhythmia Therapeutics Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Cardiac Arrhythmia Therapeutics Business (2018-2023)
Figure 52. Upsher-Smith Laboratories, LLC Revenue Growth Rate in Cardiac Arrhythmia Therapeutics Business (2018-2023)
Figure 53. Covis Pharma Revenue Growth Rate in Cardiac Arrhythmia Therapeutics Business (2018-2023)
Figure 54. Novartis AG Revenue Growth Rate in Cardiac Arrhythmia Therapeutics Business (2018-2023)
Figure 55. Mayne Pharma Group Limited Revenue Growth Rate in Cardiac Arrhythmia Therapeutics Business (2018-2023)
Figure 56. Eli Lilly and Company Revenue Growth Rate in Cardiac Arrhythmia Therapeutics Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 降圧剤のグローバル市場展望 2023年-2029年：利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬&レニン阻害薬
  • 筋緊張性ジストロフィー治療薬の世界市場2023年：ナトリウムチャネル遮断薬、三環系抗うつ薬、その他
  • 筋強直性ジストロフィー治療薬のグローバル市場展望 2023年-2029年：ナトリウムチャネル遮断薬、三環系抗うつ薬、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8712 )"不整脈治療の世界市場2023年：ナトリウムチャネル遮断薬、ベータ遮断薬、カリウムチャネル遮断薬、カルシウムチャネル遮断薬、その他" (英文：Global Cardiac Arrhythmia Therapeutics Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。